Announcements Trials
Browse Landscape

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Breast 1

Conditions

Vulvar Neoplasms 1Vaginal Neoplasms 1Uterine Cervical Neoplasms 1Prostatic Neoplasms 1Neoplastic Cells, Circulating 1Melanoma 1Esophageal Neoplasms 1Colorectal Neoplasms 1Breast Neoplasms 1

Interventions

Blood Specimen Collection 2cabazitaxel 1Watchful Waiting 1Cetuximab 14-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Neoplastic Cells, Circulating × Watchful Waiting × Clear all
NCT03161834 2021-05-21

Plasma Circulating Tumor DNA Analyses in ER+ Metastatic Breast Cancer

UNC Lineberger Comprehensive Cancer Center

Withdrawn
Breast

Breast Neoplasms, Neoplastic Cells, Circulating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡